🔎 Trials Near Me

Dachaigh › Neuroblastoma › Tennessee

Sgrùdaidhean clionaigeach Neuroblastoma ann an Tennessee

Tha 12 sgrùdaidhean airson Neuroblastoma a’ lorg phàirtichean aig làraichean ann an Tennessee.

Bailtean ann an Tennessee

Teacsa sgrùdaidh oifigeil (Beurla)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • East Tennessee Childrens Hospital, Knoxville
  • Saint Jude Children's Research Hospital, Memphis
  • The Children's Hospital at TriStar Centennial, Nashville
  • agus 1 a bharrachd
A’ fastadhÌre 3
Suas gu aois 30 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06172296

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
A’ fastadhÌre 1/2
Suas gu aois 26 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
A’ fastadhÌre 1/2
Suas gu aois 30 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06541262

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

  • Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
A’ fastadhÌre 2
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06540963

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • East Tennessee Childrens Hospital, Knoxville
  • Saint Jude Children's Research Hospital, Memphis
  • The Children's Hospital at TriStar Centennial, Nashville
  • agus 1 a bharrachd
A’ fastadhÌre 3
365 Days – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Saint Jude Children's Research Hospital, Memphis
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

  • St. Jude Children's Research Hospital, Memphis
A’ fastadhÌre 2
Aoisean 1 gu 31 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT06450041

Familial Investigations of Childhood Cancer Predisposition

  • St. Jude Children's Research Hospital, Memphis
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT03050268

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

  • St. Jude Children's Research Hospital, Memphis
A’ fastadhÌre 1
Suas gu aois 21 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04897321

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • St. Jude Children's Research Hospital, Memphis
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04901702

Neuroblastoma Biology Study

  • St. Jude Children's Research Hospital, Memphis
A’ fastadhSgrùdadh amharc
31 Days – 99 Years · Gach gnè · Air ùrachadh 23 Màrt 2026 · NCT01587300

Molecular Analysis Of Solid Tumors

  • St. Jude Children's Research Hospital, Memphis
A’ fastadhSgrùdadh amharc
Suas gu aois 25 · Gach gnè · Air ùrachadh 12 Samh 2025 · NCT01050296

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.